COVID-19 vaccines don’t raise risk of Guillain-Barre syndrome, study shows
A new study has found no evidence that COVID-19 shots increase the incidence of Guillain-Barré syndrome, according to researchers. "This is important because we can say that there is no significant increased risk of Guillain-Barré syndrome in the population," said study first author Mustafa Jaffry, a medical student at Rutgers New Jersey Medical School in New Jersey. "This information can help in ensuring confidence in vaccines, while approaching it from an objective, statistical analysis."